Recruiting NCT07324278
Hybrid Stroke Rehab With Mirror Priming
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Mirror priming, Conventional therapy.
- Who it may be relevant to
- Registry conditions: Cardiovascular Diseases, Stroke, Cerebrovascular Disorders. Basic parameters: 20 years — 80 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Taiwan
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Hybrid Stroke Rehabilitation With Mirror Priming
Overview
This trial aims to examine the effects of enhanced mirror priming, overcoming the limitations of traditional mirror therapy, to achieve optimization and personalized intervention.
Interventions
- Behavioral Mirror priming
During the mirror priming process, the movement images of the participant's unaffected limb are mirrored to the affected side to provide visual feedback. - Behavioral Conventional therapy
During conventional therapy, the participants typically receive interventions targeting the upper and lower limbs in addition to cognitive practice.
Primary outcome measures
- Fugl-Meyer Assessment [Time frame: Baseline, 2 weeks, 4 weeks, 1 month, and 3 months post-intervention.]
Secondary outcome measures (9)
- Grip and pinch power [Time frame: Baseline, 4 weeks, 1 month, and 3 months post-intervention.]
- Revised Nottingham Sensory Assessment [Time frame: Baseline, 4 weeks, 1 month, and 3 months post-intervention.]
- Berg Balance Scale [Time frame: Baseline, 4 weeks, 1 month, and 3 months post-intervention.]
- Montreal Cognitive Assessment [Time frame: Baseline, 4 weeks, 1 month, and 3 months post-intervention.]
- Motor Activity Log [Time frame: Baseline, 4 weeks, 1 month, and 3 months post-intervention.]
- ABILHAND Questionnaire [Time frame: Baseline, 4 weeks, 1 month, and 3 months post-intervention.]
- Chedoke Arm and Hand Activity Inventory [Time frame: Baseline, 4 weeks, 1 month, and 3 months post-intervention.]
- Stoke Impact Scale [Time frame: Baseline, 4 weeks, 1 month, and 3 months post-intervention.]
- Stroke Self-Efficacy Questionnaire [Time frame: Baseline, 4 weeks, 1 month, and 3 months post-intervention.]
Eligibility criteria
Inclusion criteria
- A first-ever unilateral stroke ≥3 months
- Age between 20 and 80 years
- Baseline Fugl-Meyer Assessment Upper Extremity (FMA-UE) score >10
- No severe spasticity in any joints of the affected arm
- Ability to follow the instructions
- No participation in other studies during the study period
- Willingness to provide informed written consent.
Exclusion criteria
1\. Serious medical problems or poor physical conditions that might be detrimental to study participation.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Double blind
- Primary purpose
- Treatment
Study locations
Taiwan · 1 center
- E-Da Hospital — Kaohsiung City
Identifiers
NCT: NCT07324278 · ISU-OT-Li-02